Kenvue Inc. (NYSE:KVUE) Receives $20.08 Average PT from Analysts

Kenvue Inc. (NYSE:KVUE) has been assigned an average rating of “Hold” from the fifteen research firms that are presently covering the firm, MarketBeat.com reports. Twelve research analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 12 month target price among brokers that have issued ratings on the stock in the last year is $19.50.

A number of equities analysts have weighed in on KVUE shares. UBS Group upped their price target on Kenvue from $17.00 to $19.00 and gave the stock a “neutral” rating in a research report on Wednesday, February 18th. Weiss Ratings reissued a “hold (c-)” rating on shares of Kenvue in a research report on Friday, January 9th. Edward Jones downgraded shares of Kenvue from a “strong-buy” rating to a “hold” rating in a research report on Monday, November 3rd. Jefferies Financial Group lowered shares of Kenvue from a “buy” rating to a “hold” rating and lowered their price target for the company from $23.00 to $18.00 in a research note on Friday, January 30th. Finally, Zacks Research raised shares of Kenvue from a “strong sell” rating to a “hold” rating in a research report on Wednesday, November 26th.

Kenvue Price Performance

KVUE stock opened at $18.78 on Monday. The stock has a 50-day moving average price of $17.64 and a two-hundred day moving average price of $17.56. Kenvue has a 1 year low of $14.02 and a 1 year high of $25.17. The stock has a market cap of $35.99 billion, a PE ratio of 24.38, a price-to-earnings-growth ratio of 4.36 and a beta of 0.59. The company has a current ratio of 0.96, a quick ratio of 0.69 and a debt-to-equity ratio of 0.66.

Kenvue (NYSE:KVUE) last posted its quarterly earnings data on Tuesday, February 17th. The company reported $0.27 earnings per share for the quarter, topping the consensus estimate of $0.22 by $0.05. The company had revenue of $3.78 billion during the quarter, compared to analysts’ expectations of $3.68 billion. Kenvue had a return on equity of 19.72% and a net margin of 9.72%.Kenvue’s revenue for the quarter was up 3.2% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.26 earnings per share. Equities analysts forecast that Kenvue will post 1.14 EPS for the current fiscal year.

Kenvue Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, February 25th. Investors of record on Wednesday, February 11th were given a dividend of $0.2075 per share. The ex-dividend date of this dividend was Wednesday, February 11th. This represents a $0.83 annualized dividend and a yield of 4.4%. Kenvue’s dividend payout ratio is 107.79%.

Insiders Place Their Bets

In related news, Director Jeffrey C. Smith purchased 3,200,000 shares of the stock in a transaction on Friday, December 12th. The shares were purchased at an average price of $17.37 per share, with a total value of $55,584,000.00. Following the transaction, the director directly owned 27,307,632 shares of the company’s stock, valued at $474,333,567.84. This trade represents a 13.27% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 1.68% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Kenvue

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Vanguard Group Inc. lifted its stake in Kenvue by 0.7% in the fourth quarter. Vanguard Group Inc. now owns 234,951,484 shares of the company’s stock valued at $4,052,913,000 after acquiring an additional 1,604,040 shares during the last quarter. State Street Corp increased its stake in shares of Kenvue by 3.5% during the 4th quarter. State Street Corp now owns 118,865,134 shares of the company’s stock worth $2,050,424,000 after purchasing an additional 4,063,257 shares during the last quarter. Geode Capital Management LLC raised its holdings in shares of Kenvue by 0.8% in the 4th quarter. Geode Capital Management LLC now owns 49,862,574 shares of the company’s stock valued at $856,778,000 after purchasing an additional 371,322 shares during the period. Independent Franchise Partners LLP lifted its stake in Kenvue by 56.3% in the 4th quarter. Independent Franchise Partners LLP now owns 48,146,476 shares of the company’s stock valued at $830,527,000 after purchasing an additional 17,343,785 shares during the last quarter. Finally, Norges Bank acquired a new stake in Kenvue in the 4th quarter valued at about $756,862,000. 97.64% of the stock is owned by institutional investors.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.